Antibiotic resistance

Biosecurity and Bioterrorism

Volumn 7, Issue 4, 2009, Pages 371-377

  Rambhia, Kunal J ^a   Gronvall, Gigi Kwik ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGICAL WARFARE; CLINICAL MEDICINE; DISASTER PLANNING; DRUG APPROVAL; GENETICS; HUMAN; ORGANIZATION AND MANAGEMENT; POLITICS; PRESCRIPTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; BIOTERRORISM; CLINICAL MEDICINE; DISASTER PLANNING; DRUG APPROVAL; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; POLITICS; SECURITY MEASURES; UNITED STATES;

BACTERIA (MICROORGANISMS);

EID: 77749252449     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2009.1105     Document Type: Article

References (36)

1. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5(1):9-17.
2. Elixhauser A, Steiner C. Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993-2005. Statistical Brief #35. Rockville, MD: Agency for Healthcare Research and Quality [AHRQ]; July 2007.
3. Projan SJ. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol Oct 2003;6(5): 427-430.
4. Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect Aug 2006;12 Suppl 5:25-34.
5. Mossialos E, Morel C, Edwards S, Berenson J, Gemmill-Toyama M, Brogan D. Policies and Incentives for Promoting Innovation in Antibiotic Research. London: London School of Economics and Political Science; 2009. http://www2.lse.ac.uk/LSEHealthAndSocialCare/LSEHealth/News/ Policies%20and%20incentives%20report.pdf. Accessed October 23, 2009.
6. Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis Jul 2005;5(7):450-459.
7. Federation of American Scientists. Antibiotic Resistance: Case Study. http://www.fas.org/biosecurity/education/dualuse/FAS-Levy/index.html. Accessed July 21, 2009.
8. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004;38(9):1279-1286.
9. Alliance for the Prudent Use of Antibiotics. About bacteria & antibiotics. http://www.tufts.edu/med/apua/Q&A/Q&A-bact.html. Accessed March 31, 2009.
10. Roberts JA, Kruger P, Paterson DL, Lipman J. Antibiotic resistance - what's dosing got to do with it? Crit Care Med Aug 2008;36(8):2433-2440.
11. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epide-miologic findings. Emerg Infect Dis Oct 2002;8(10):1019-1028.
12. Trust for America's Health. Ready or Not? December 2008. http://healthyamericans.org/assets/files/bioterror-report-2008.pdf. Accessed July 21, 2009.
13. U.S. Centers for Disease Control and Prevention. Anthrax Q & A: Treatment. Updated March 25, 2005. http://www.bt.cdc.gov/agent/anthrax/faq/ treatment.asp. Accessed August 5, 2009.
14. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287(17):2236-2252.
15. Price LB, Vogler A, Pearson T, Busch JD, Schupp JM, Keim P. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Anti-microb Agents Chemother Jul 2003;47(7):2362-2365.
16. Brook I, Elliott TB, Pryor HI 2d, et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents 2001;18(6):559-562.
17. Welch TJ, Fricke WF, McDermott PF, et al. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2007;2(3):e309.
18. Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ, Rubinstein E. Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother Aug 2004; 54(2):424-428.
19. Alibek K. Behind the mask: biological warfare. Perspective September-October 1998;IX(1). http://www.bu.edu/iscip/vol9/Alibek.html. Accessed November 5, 2009.
20. World Health Organization. Antimicrobial resistance. http://www.who.int/ mediacentre/factsheets/fs194/en/. Accessed March 31, 2009.
21. Kardas P, Pechere JC, Hughes DA, Cornaglia G. A global survey of antibiotic leftovers in the outpatient setting. Int J Antimicrob Agents Dec 2007;30(6):530-536.
22. Gever J. Antibiotic reactions send thousands to emergency rooms. MedPage Today August 13, 2008. http://www.medpagetoday.com/ProductAlert/ Prescriptions/10549. Accessed October 23, 2009. 23. Union of Concerned Scientists. European Union bans antibiotics for growth promotion. Last revised February 14, 2006. http://www.ucsusa.org/food-and-agriculture/solutions/wise- antibiotics/european-union-bans.html. Accessed July 21, 2009.
23. Silbergeld EK, Davis M, Leibler JH, Peterson AE. One reservoir: redefining the community origins of antimicrobial-resistant infections. Med Clin North Am Nov 2008;92(6): 1391-1407, xi.
24. Chapin A, Rule A, Gibson K, Buckley T, Schwab K. Airborne multidrug-resistant bacteria isolated from a concentrated swine feeding operation. Environ Health Perspect Feb 2005;113(2):137-142.
25. Keep Antibiotics Working. Linking antibiotic use in livestock & poultry to increasing resistance in humans. July 2005. http://www. keepantibioticsworking.com/new/resources-library.cfm?RefID=36444. Accessed July 21, 2009.
26. Silbergeld EK, Graham J, Price LB. Industrial food animal production, antimicrobial resistance, and human health. Annu Rev Public Health 2008;29:151-169.
27. Shea KM. Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics. Pediatrics Sep 2004;114(3):862-868.
28. Cimitile M. Worried about antibiotics in your beef? Vegetables may be no better. Sci Am January 6, 2009. http://www.scientificamerican.com/ article.cfm?id=vegetables-contain-antibiotics. Accessed November 5, 2009.
29. The Pew Campaign on Human Health and Industrial Farming. Important human medicines used on industrial animal farms. http://www.saveantibiotics.org/ resources/Important-Human-Medicines.pdf. Accessed July 21, 2009.
30. Keep Antibiotics Working. Fluoroquinolones: A (slow) success story. http://www.keepantibioticsworking.com/new/indepth-fluoro.cfm. Accessed July 23, 2009.
31. Unicomb LE, Ferguson J, Stafford RJ, et al. Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis 2006;42(10):1368-1374.
32. To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. Slaughter L, trans. 111th Congress 1st Session ed; 2009.
33. Congresswoman Louise Slaughter. Slaughter asks GAO for additional data on antibiotic use in animals. September 21, 2009. http://www.louise.house.gov/ index.php?option=com-content&view=article&id=1306:slaughter-asks-gao- for-additional-data-on-antibiotic-use-in-animals&catid=41: press-releases&Itemid=109. Accessed October 20, 2009.
34. Congresswoman Louise Slaughter. Slaughter asks House to support antibiotics legislation, warns of continuing food safety issues. October 7, 2009. http://www.louise.house.gov/index.php?option=com-content&view= article&id=1365:slaughter-asks-house-to-support-antibiotics-legislation- warns-of-continuing-food-safety-issues&catid=41:press-releases&Itemid= 109. Accessed October 20, 2009.
35. Congresswoman Louise Slaughter. Slaughter asks White House to ban excessive use of antibiotics in farm animals. October 8, 2009. http://www.louise.house.gov/index.php?option=com-content&view= article&id=1367:slaughter-asks-white-house-to-ban-excessive-use-of- antibiotics-in-farm-animals-&catid=41:press-releases&Itemid=109. Accessed October 20, 2009.
36. Testimony of Joshua M. Sharfstein, MD. Hearing on H.R. 1549 "Preservation of Antibiotics for Medical Treatment Act of 2009" [House Committee on Rules July 13, 2009. http://www.rules.house.gov/111/oj/hr5419/ statements/sharfstein-hr1549-111.pdf. Accessed October 23, 2009.